The Absorbable Collagen Membrane ecosystem spans upstream raw‑material sourcing, midstream membrane fabrication and integration, and downstream clinical deployment. Upstream, animal‑derived collagen and ancillary polymers are supplied by specialty biopolymer producers that must meet sterility and biocompatibility specifications. Midstream participants convert these inputs into membranes through extrusion, cross‑linking, and sterilization processes, often under technology licences from biomedical innovators. Downstream, the membranes are packaged, distributed, and ultimately implanted by oral‑maxillofacial surgeons, periodontists, and other clinicians. Value is generated by transforming biological feedstock into a regulated medical device and captured through product pricing, service contracts, and reimbursement mechanisms.